[HTML][HTML] Experimental and clinical treatment of Chagas disease: a review

PAS Junior, I Molina, SMF Murta… - The American journal …, 2017 - ncbi.nlm.nih.gov
Chagas disease (CD) is caused by the protozoan parasite Trypanosoma cruzi that infects a
broad range of triatomines and mammalian species, including man. It afflicts 8 million …

[HTML][HTML] Randomized trial of posaconazole and benznidazole for chronic Chagas' disease

I Molina, J Gómez i Prat, F Salvador… - … England Journal of …, 2014 - Mass Medical Soc
Background Current therapeutic options for Chagas' disease are limited to benznidazole
and nifurtimox, which have been associated with low cure rates in the chronic stage of the …

From latency to overt bone metastasis in breast cancer: potential for treatment and prevention

F Salvador, A Llorente, RR Gomis - The Journal of pathology, 2019 - Wiley Online Library
Bone metastasis is present in a high percentage of breast cancer (BCa) patients with distant
disease, especially in those with the estrogen receptor‐positive (ER+) subtype. Most cells …

[HTML][HTML] Biological therapy in systemic lupus erythematosus, antiphospholipid syndrome, and Sjögren's syndrome: Evidence-and practice-based guidance

A Marinho, J Delgado Alves, J Fortuna, R Faria… - Frontiers in …, 2023 - frontiersin.org
Systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), and Sjögren's
syndrome (SS) are heterogeneous autoimmune diseases. Severe manifestations and …

Lysyl oxidase‐like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal‐like breast carcinomas

G Moreno‐Bueno, F Salvador, A Martín… - EMBO molecular …, 2011 - embopress.org
Basal‐like breast carcinoma is characterized by the expression of basal/myoepithelial
markers, undifferentiated phenotype, highly aggressive behaviour and frequent triple …

Lysyl oxidase–like protein LOXL2 promotes lung metastasis of breast cancer

F Salvador, A Martin, C López-Menéndez… - Cancer research, 2017 - AACR
The lysyl oxidase–like protein LOXL2 has been suggested to contribute to tumor
progression and metastasis, but in vivo evidence has been lacking. Here we provide …

MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer

S Gawrzak, L Rinaldi, S Gregorio, EJ Arenas… - Nature cell …, 2018 - nature.com
For many patients with breast cancer, symptomatic bone metastases appear after years of
latency. How micrometastatic lesions remain dormant and undetectable before initiating …

Lysyl oxidase‐like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression

A Martin, F Salvador, G Moreno‐Bueno… - The EMBO …, 2015 - embopress.org
Abstract Lysyl oxidase‐like 2 (LOXL 2) is involved in a wide range of physiological and
pathological processes, including fibrosis and tumor progression, implicating intracellular …

[HTML][HTML] Prevalence and molecular characterization of Strongyloides stercoralis, Giardia duodenalis, Cryptosporidium spp., and Blastocystis spp. isolates in school …

E Dacal, JM Saugar, A de Lucio… - Parasites & vectors, 2018 - Springer
Background Human infections by the gastrointestinal helminth Strongyloides stercoralis and
the enteric protozoans Giardia duodenalis, Cryptosporidium spp. and Blastocystis spp. are …

[HTML][HTML] Usefulness of Strongyloides stercoralis serology in the management of patients with eosinophilia

F Salvador, E Sulleiro… - The American journal …, 2014 - ncbi.nlm.nih.gov
Strongyloides stercoralis infection is being increasingly diagnosed out of endemic areas.
The aim of this study is to evaluate the usefulness of S. stercoralis serology for the …